These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 9041318)
41. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
42. Encouraging generic use can yield significant savings. Zimmerman C Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854 [TBL] [Abstract][Full Text] [Related]
43. Desensitization to pancreatic enzyme intolerance in a child with cystic fibrosis. Chamarthy LM; Reinstein LJ; Schnapf B; Good RA; Bahna SL Pediatrics; 1998 Jul; 102(1):e13. PubMed ID: 9651465 [TBL] [Abstract][Full Text] [Related]
44. CYSTIC FIBROSIS WITH FECAL RETENTION (MECONIUM ILEUS EQUIVALENT): REPORT OF TWO CASES. SIGLER RM; REEVES HH; LYNN HB; BURKE EC Mayo Clin Proc; 1965 Jun; 40():477-80. PubMed ID: 14299795 [No Abstract] [Full Text] [Related]
45. Patients who pay out-of-pocket receive lower-cost drugs. Am J Health Syst Pharm; 1998 Aug; 55(15):1556-8. PubMed ID: 9706178 [No Abstract] [Full Text] [Related]
46. The cost of gullibility. Roach ES Arch Neurol; 2009 Nov; 66(11):1418-20. PubMed ID: 19901178 [No Abstract] [Full Text] [Related]
47. Efficiency of two pancreatic extracts in patients with cystic fibrosis. Baran D; Loeb H; Mozin MJ Acta Paediatr Belg; 1976; 29(2):117-22. PubMed ID: 998217 [No Abstract] [Full Text] [Related]
48. And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange. Burkhart CG J Drugs Dermatol; 2004; 3(1):11. PubMed ID: 14964740 [No Abstract] [Full Text] [Related]
49. Does generic entry lower the prices paid for pharmaceuticals in Australia? A comparison before and after the introduction of the mandatory price-reduction policy. Spinks J; Chen G; Donovan L Aust Health Rev; 2013 Nov; 37(5):675-81. PubMed ID: 24160374 [TBL] [Abstract][Full Text] [Related]
54. The MAC program and advisors to the government. Shubin S Hosp Formul; 1981 Aug; 16(8):869-72, 877-9. PubMed ID: 10252371 [No Abstract] [Full Text] [Related]
55. Medco becomes standalone firm. Thompson CA Am J Health Syst Pharm; 2003 Oct; 60(19):1940-1. PubMed ID: 14531236 [No Abstract] [Full Text] [Related]
56. Generic boost. Bill, acquisitions could help hospitals save money. Rhea S Mod Healthc; 2009 Apr; 39(16):17. PubMed ID: 19419134 [No Abstract] [Full Text] [Related]
57. Reliability and risks of generic psychopharmacologic agents. Gelenberg AJ Essent Psychopharmacol; 2005; 6(6):348-55. PubMed ID: 16459758 [No Abstract] [Full Text] [Related]
58. [Medication supply of privately insured patients in 2010]. Wild F Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648 [No Abstract] [Full Text] [Related]
59. Is fibrosing colonopathy an immune mediated disease? Lee J; Ip W; Durie P Arch Dis Child; 1997 Jul; 77(1):66-70. PubMed ID: 9279159 [TBL] [Abstract][Full Text] [Related]